Jinlong Wang
Zhenjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Retraction: Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p.
Journal: Oncotarget
Published: January 20, 2025
Corrigendum to circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axis.
Journal: Biochemical and biophysical research communications
Published: December 13, 2021
Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 30, 2020
Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 13, 2020
Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis.
Journal: Cell death & disease
Published: July 30, 2019
Long noncoding RNA OIP5-AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR-217.
Journal: Journal of cellular physiology
Published: November 03, 2018
circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axis.
Journal: Biochemical and biophysical research communications
Published: May 06, 2018
Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis.
Journal: Journal of cancer research and clinical oncology
Published: November 05, 2017
Polygonatum odoratum lectin promotes BECN1 expression and induces autophagy in malignant melanoma by regulation of miR1290.
Journal: OncoTargets and therapy
Published: October 26, 2017
miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Journal: Biochemical and biophysical research communications
Published: October 26, 2017
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma.
Journal: OncoTargets and therapy
Published: March 11, 2017
Last Updated: 09/26/2026